Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Organogenesis Holdings Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2028 | $372.30M | $372.05M - $372.54M | $40.10M | -$0.14 | 2 |
| Dec 2027 | $339.57M | $333.45M - $345.70M | $36.57M | -$0.275 | 2 |
| Dec 2026 | $282.87M | $281.73M - $284.01M | $30.47M | -$0.82 | 2 |
| Dec 2025 | $511.07M | $505.11M - $517.02M | $55.05M | $0.152 | 1 |
| Dec 2024 | $465.62M | $460.20M - $471.04M | $50.15M | -$0.073 | 2 |
| Dec 2023 | $448.39M | $443.17M - $453.61M | $48.29M | -$0.126 | 1 |
| Dec 2022 | $458.80M | $458.07M - $459.53M | $46.02M | $0.12 | 1 |
| Dec 2021 | $463.90M | $460.15M - $467.64M | $46.53M | $0.415 | 1 |
| Dec 2020 | $336.75M | $334.03M - $339.47M | $33.78M | $0.115 | 1 |
| Dec 2019 | $256.75M | $254.68M - $258.82M | $25.75M | -$0.49 | 1 |